Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.12 | €3.60 | 221.635% |
| Sanofi S.A. | 5 | 0 | 1 | 0 | €94.47 | €99.50 | 5.324% |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €26.40 | €28.29 | 7.162% |
| X4 Pharmaceuticals, Inc. | 5 | 0 | 2 | 0 | €0.98 | €2.78 | 183.400% |
| Viking Therapeutics Inc | 5 | 0 | 2 | 0 | €68.38 | €100.00 | 46.242% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.66 | €3.00 | 80.723% |
| Immunogen Inc. | 5 | 0 | 1 | 0 | €28.97 | - | - |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €20.20 | €45.10 | 123.243% |
| Dr. Reddy's Laboratories Ltd. ADR | 6 | 1 | 1 | 0 | €64.50 | €74.65 | 15.729% |
| Eledon Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €2.22 | €12.18 | 448.577% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Purple Biotech Ltd. ADR | 5 | 0 | 1 | 0 | €0.51 | €9.21 | 1723.168% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.64 | €4.16 | 153.887% |
| Kezar Life Sciences | 5 | 0 | 1 | 0 | €0.75 | €18.56 | 2391.812% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.26 | €19.86 | 217.331% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 1 | 0 | €1.86 | €6.45 | 247.662% |
| Elanco Animal Health Inc. | 7 | 3 | 1 | 0 | €15.78 | €15.58 | -1.235% |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €38.98 | €70.00 | 79.579% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.10 | €10.00 | 23.457% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.68 | €5.00 | 6.838% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 0 | 1 | €4.78 | €12.80 | 167.814% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €42.00 | - | - |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €3.00 | - | - |